Joseph C. Glorioso, Ph.D.
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Gene Therapy, Herpes simplex virus, Chronic PainGoogle:
"Joseph Glorioso"Mean distance: 15.85 (cluster 11)
Children
Sign in to add traineeAlan L. Goldin | grad student | University of Michigan | |
Rahul Srinivasan | grad student | 2006 | University of Pittsburgh |
Marianna Tsvitov | grad student | 2006 | University of Pittsburgh |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Marzulli M, Hall BL, Zhang M, et al. (2023) Novel mutations in U24 and gH rescue efficient infection of an HSV vector retargeted to TrkA. Molecular Therapy. Methods & Clinical Development. 30: 208-220 |
Kuroda S, Miyagawa Y, Sukegawa M, et al. (2022) Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors. Molecular Therapy. Methods & Clinical Development. 26: 132-143 |
Otani Y, Yoo JY, Lewis CT, et al. (2022) NOTCH induced MDSC recruitment after oHSV virotherapy in CNS cancer models modulates anti-tumor immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Kennedy EM, Farkaly T, Grzesik P, et al. (2020) Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability. Molecular Therapy Oncolytics. 18: 476-490 |
Glorioso JC, Cohen JB, Goins WF, et al. (2020) Oncolytic HSV Vectors and Anti-Tumor Immunity. Current Issues in Molecular Biology. 41: 381-468 |
Kuroda S, Miyagawa Y, Sato Y, et al. (2020) Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes. Molecular Therapy. Methods & Clinical Development. 17: 612-621 |
Otani Y, Yoo JY, Chao S, et al. (2020) Oncolytic HSV infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Tuzmen C, Cairns TM, Atanasiu D, et al. (2020) Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies. Molecular Therapy. Methods & Clinical Development. 16: 145-154 |
Goins WF, Huang S, Hall B, et al. (2020) Engineering HSV-1 Vectors for Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 2060: 73-90 |
Suzuki T, Saito T, Shimizu N, et al. (2020) Mp54-18 Improvement Of Detrusor Overactivity By Ivermectin-Mediated Activation Of Double Mutant Glycine Receptors Delivered By Herpes Simplex Virus (Hsv) Vectors In Mice With Spinal Cord Injury (Sci) The Journal of Urology. 203 |